Trial of Screening for ALOA-IgG AtheroAbzyme Test

Clinical trial NCT01272986 · COMPLETED

Trial details

NCT number: NCT01272986
Sponsor: Omicron Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Myocardial Ischemia Acute Coronary Syndrome

Start date: 2011-01-01
Primary completion: 2011-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.